Cancer Immunotherapy News and Research

RSS
FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer

JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer

Combination therapy shows great promise as a new strategy against advanced lung cancer

Combination therapy shows great promise as a new strategy against advanced lung cancer

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

Macrophages play an unexpected role in the complicated obesity-cancer connection

Macrophages play an unexpected role in the complicated obesity-cancer connection

Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy

Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy

Researchers identify a potential metabolic target for cancer immunotherapy

Researchers identify a potential metabolic target for cancer immunotherapy

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

Understanding the role of tumor-associated fibrosis in immunotherapy resistance

Understanding the role of tumor-associated fibrosis in immunotherapy resistance

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

New subset of T cells may enhance cancer immunotherapy

New subset of T cells may enhance cancer immunotherapy

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy

What is the ‘immune self,’ and how can this concept benefit immunological research?

What is the ‘immune self,’ and how can this concept benefit immunological research?

Breakthrough research offers promise for developing new immune therapies for cancer

Breakthrough research offers promise for developing new immune therapies for cancer

Enhancing the ability of natural killer cells to combat hematologic malignancies

Enhancing the ability of natural killer cells to combat hematologic malignancies

NK cells' role in cancer therapy resistance unveiled

NK cells' role in cancer therapy resistance unveiled

Ketone supplement boosts efficacy of prostate cancer immunotherapy

Ketone supplement boosts efficacy of prostate cancer immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.